TREATMENT OF UPPER RESPIRATORY TRACT BACTERIAL INFECTIONS IN CHILDREN WITH BACTERIOPHAGE
DOI:
https://doi.org/10.52340/jecm.2025.01.04Keywords:
Bacteriophage, bacterial infection, respiratory tract, childrenAbstract
The study aims to assess the efficacy of bacteriophage therapy in pediatric patients with upper respiratory tract bacterial infections. The study is a prospective, open, controlled trial undertaken from 2021 to 2023 at the Pediatric Academic Clinic of Tbilisi State Medical University named after G. Zhvania. A total of 108 patients were enrolled in the trial, comprising 54 in the main group and 54 in the control group. The participants were youngsters aged 3-7 years, with 52 males (48.2%) and 56 females (51.8%). Clinical diagnosis includes acute streptococcal tonsillitis (62 cases) and acute streptococcal tonsillitis (46 cases). Both the main and control groups had an equal distribution. Patients in the basic group received both standard antibiotic therapy and oral bacteriophage. In the control group, only antibiotics were administered.
The collected findings were statistically analyzed utilizing Fuzzy logic techniques, and the efficacy of bacteriophage therapy in the treatment of bacterial infections of the upper respiratory tract in pediatric practice was determined. Taking this into consideration, we believe that research in this area should be extended.
Downloads
References
Systemic antimycotic and antifungal use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. /Adriaenssens N et all/ Journal of Antimicrobial Chemotherapy, Volume 70, Issue 7, e2173–2175, Jul 2015
Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey /Versporten A et all/. The Lancet health, Volume 6, No. 6, e619–e629, Jun 2018
Vázquez R, García E, García P. "Phage lysins for fighting bacterial respiratory infections: A new generation of antimicrobials" . Front Immunol. 2018; 9:2252.
Aminov, R.; Caplin, J.; Chanishvili, N.; Coffey, A.; Cooper, I.; De Vos, D.; Doškar, J.; Friman, V.; Kurtböke, I.; Pantucek, R.; et al. Application of bacteriophages. Microbiol. Aust. 2018, 38, 63–66.
Vandenheuvel D et al. Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials Annual Review of Virology, Volume 2, e599-618, Nov 2015
Lehman SM et al. Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant Staphylococcus aureus Infections Virusses 2019, Volume 11, No. 1, e88, Jun 2019
Reindel R et al Phage Therapy: Considerations and Challenges for Development Clinical Infectious Diseases, Volume 64, No 11, e1589–1590, Jun 2017
Pagava K et al. What happens when the child gets bacteriophage per os? Georgian Medical News, e196-197, Jul 2011
Pagava K et al. Some immunological changes in children with bacterial infections treated with bacteriophages. Georgian Medical News, e64-69, Nov 2012
Kiseliova T, Pagava K. Fuzzy approaches in pediatrics. Georgian Medical News, May 2014,(230):38-46
J D Jones , D Varghese , R Pabary , R J Langley The potential of bacteriophage therapy in the treatment of paediatric respiratory infections /Paediatr Respir Rev. 2022 Dec;44:70-77.
Downloads
Published
How to Cite
Issue
Section
